← All organizations
Highest phase reached
Phase 4
First clinical trial
Nov 30, 2009Last known activity
Oct 1, 2023
Timeline
No events for the selected filters.
Drugs by trial phase (23 distinct, 10 trials)
Phase 4 (7 own, 0 via acquisition)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (4 own, 0 via acquisition)
Other trials (11 own, 0 via acquisition)
Indications
Recent trials (12)
- NCT05851508CollaboratorPhase 3Oct 1, 2023
- NCT05454709Overall official - principal investigatorPhase 2Jun 1, 2023
- NCT04481256CollaboratorN/AOct 1, 2020
- NCT05693688CollaboratorPhase 4Dec 1, 2017
- NCT02054442CollaboratorPhase 1/Phase 2Aug 1, 2016
- NCT02422888CollaboratorPhase 4May 1, 2015
- NCT02056236CollaboratorN/AApr 1, 2014
- NCT01459627Study chairPhase 4Dec 31, 2011
- NCT01459627OfficialPhase 4Dec 31, 2011
- NCT01379898CollaboratorPhase 4Dec 1, 2011
- NCT01379898Overall official - principal investigatorPhase 4Dec 1, 2011
- NCT01139489CollaboratorN/ANov 30, 2009
Details
- Founded
- Enschede, DE
- Last known activity
- Oct 1, 2023